HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides

Clinical and Experimental Immunology

Volumn 134, Issue 2, 2003, Pages 351-359

  Frauendorf, E ^a   Von Goessel, H ^a   May, E ^b,c   Marker Hermann E ^a,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Univ of TX S W Medical Center   (United States)

^c BAYER PHARMA AG   (Germany)

^d DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Arthritogenic peptide; Spondyloarthropathies; TCRBV CDR3 spectratyping

Indexed keywords

CHROMIUM; HLA B27 ANTIGEN; HLA B2705 ANTIGEN; LEUCYLARGINYLARGINYLTYROSYLGLUTAMYLASPARAGINYLGLYCYLLYSINE; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENTEROBACTERIACEAE; FEMALE; HUMAN; IMMUNOASSAY; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; RISK FACTOR; SEQUENCE HOMOLOGY; SPECTROSCOPY; SPONDYLOARTHROPATHY; SYNOVIAL FLUID; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; COMPLEMENTARITY DETERMINING REGIONS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242708850     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02289.x     Document Type: Article

References (28)

1. Baum H, Davies H, Peakman M. Molecular mimicry in the MHC:. hidden clues to autoimmunity? Immunol Today 1996; 17:64-70.
2. Wildner G, Thurau SR. Cross-reactivity between an HLA-B27 derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 1994; 24:2579-85.
3. Wildner G, Diedrichs-Mohring M, Thurau SR. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin. Eur J Immunol 2002; 32:299-306.
4. Märker-Hermann E, Meyer zum Büschenfelde KH, Wildner G. HLA-B27 derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum 1997; 40:2047-54.
5. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins. The role of genes, HLA, and the environment. Arthritis Rheum 1997; 40:1823-8.
6. + healthy control subjects in a limiting dilution study and determination of the specifity of synovial fluid T cell clones. Arthritis Rheum 1995; 38:1277-82.
7. Höhler T, Hug R, Schneider PM et al. Ankylosing spondylitis in monocygotic twins: studies on immunological parameters. Ann Rheum Dis 1999; 58:435-40.
8. + monozygotic twins. Clin Exp Immunol 2001; 123:315-22.
9. Benjamin R, Parham P. Guilt by association: HLA x B27 and ankylosing spondylitis. Immunol Today 1990; 11:137-42.
10. Hermann EYuDT, Meyer zum Büschenfelde KH, Fleischer B. HLA-B27 restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342:646-50.
11. Scofield RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: Contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci USA 1993; 90:9330-4.
12. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptides from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995; 345:1542-4.
13. Boisgérault F, Tieng V, Stolzenberg MC et al. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondyloarthropathies. J Clin Invest 1996;98:2764-70.
14. Houbiers JGA, Nijman HW, van der Burh SH et al. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol 1993; 23:2072-7.
15. + T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J Infect Dis 1998; 178:260-5.
16. + T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Meth 1997; 203:141-52.
17. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc Natl Acad Sci USA 1989; 86:8941-5.
18. Genevee C, Diu A, Nierat J et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992; 22:1261-9.
19. May E, Märker-Hermann E, Wittig BM, Zeitz M, Meyer zum Büschenfelde KH, Duchmann R. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 2000; 119:1745-55.
20. Gorski J, Yassai M, Zhu X, Kissela B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152:5109-19.
21. Maslanka K, Piatek T, Gorski J, Yassai M, Gorski J. Molecular Analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol 1995; 44:28-34.
22. Colbert RA, Rowland-Jones SL, McMichael AJ, Frelinger JA. Differences in peptide presentation between B27 subtypes the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity 1994; 1:121-30.
23. Villadangos JA, Galocha B, Garcia F, Albar JP, Löpez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specifity of B*2703. Eur J Immunol 1995; 25:2370-7.
24. + T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 2000; 106:47-53.
25. + T lymphocytes in IFN-γ ELISPOT assays. J Immunol Meth 2002; 259:95-110.
26. Alvarez I, Sesma L, Marcilla M et al. Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome. J Biol Chem 2001; 276:32729-37.
27. May E, Dulphy N, Frauendorf E et al. Highly conserved TCR β chain usage in reactive arthritis, evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 2002; 60:299-308.
28. Duchmann R, May E, Ackermann B, Goergen B, Meyer zum Büschenfelde KH, Märker-Hermann E. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria of self-antigens are dominated by closely related TCRBV gene segments: a study in patients with reactive arthritis. Scand J Immunol 1996; 43:101-8.